Research / FCUV / Fundamental state Inspectable configuration
State dimensions Filing 0001683168-22-007765 General Corporate
Capex intensity 0th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.capex_revenue_ratio
-0.84% · OPTIONAL · VALID
Operating cash generation 5th Own-history percentile · N=19
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1130.45% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=18
Evidence method Yoy · gp.fundamentals.revenue
-90.44% · CORE · VALID
Inventory pressure 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
80.97% · OPTIONAL · VALID
Gross margin 53th Own-history percentile · N=19
Evidence method Level · gp.fundamentals.gross_margin
30.03% · CORE · VALID
Operating margin 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-1605.77% · CORE · VALID
R&D intensity 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
219.46% · OPTIONAL · VALID
SBC intensity 6th Own-history percentile · N=16
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 6/6 normalized Level 3 Jun 30, 2026 5/6 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 12.73%
Current -0.84%
Delta -13.57% Cash Generation Increased
Previous -1310.62%
Current -1130.45%
Delta 180.16% Growth Decreased
Previous -75.30%
Current -90.44%
Delta -15.15% Inventory Pressure Decreased
Previous 87.03%
Current 80.97%
Delta -6.06% Profitability Increased
Previous -1864.65%
Current -1605.77%
Delta 258.88% R And D Intensity Decreased
Previous 258.90%
Current 219.46%
Delta -39.45% Sbc Intensity Increased
Previous -12.38%
Current 0.00%
Delta 12.38% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.